Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

2.9%

16 terminated/withdrawn out of 552 trials

Success Rate

91.4%

+4.9% vs industry average

Late-Stage Pipeline

20%

108 trials in Phase 3/4

Results Transparency

2%

4 of 169 completed trials have results

Key Signals

126 recruiting4 with results11 terminated5 withdrawn

Enrollment Performance

Analytics

N/A
170(48.7%)
Phase 4
92(26.4%)
Phase 2
51(14.6%)
Phase 3
16(4.6%)
Phase 1
16(4.6%)
Early Phase 1
4(1.1%)
349Total
N/A(170)
Phase 4(92)
Phase 2(51)
Phase 3(16)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (552)

Showing 20 of 552 trials
NCT07525999Phase 4Not Yet Recruiting

Dexmedetomidine-esketamine Combination and Chronic Postsurgical Pain After Spinal Surgery

Role: lead

NCT06385652Early Phase 1Recruiting

PET Imaging Study of 68Ga-NB381 in Multiple Myeloma

Role: lead

NCT07532122Completed

Postoperative Anxiety and Depression Among Chinese Elderly Patients

Role: collaborator

NCT07530627Phase 1Completed

Efficacy of UMT in CG Patients With PL

Role: lead

NCT07523321Phase 4Not Yet Recruiting

Dexmedetomidine-esketamine Combination and Moderate-to-severe Pain After Spinal Surgery

Role: lead

NCT07523334Phase 4Not Yet Recruiting

Impact of Esketamine on Delayed Neurocognitive Recovery in Older Patients

Role: lead

NCT07308756Phase 4Recruiting

Impact of Perioperative Dexmedetomidine and Esketamine on Postoperative Quality of Recovery

Role: lead

NCT07145775Phase 4Completed

Dexmedetomidine-esketamine-ropivacaine Versus Sufentanil-ropivacaine for Epidural Labor Analgesia

Role: lead

NCT07525986Phase 4Not Yet Recruiting

Anrikefon-based Patient-controlled Intravenous Analgesia Following Laparoscopic Surgery

Role: lead

NCT07511595Not Yet Recruiting

Blood mNGS for Diagnosing Invasive Pulmonary Fungal Disease in Hematologic Patients

Role: collaborator

NCT06062550Phase 4Active Not Recruiting

Different Dose Esketamine and Dexmedetomidine Combination for Supplemental Analgesia After Scoliosis Correction Surgery

Role: lead

NCT07479602Phase 4Recruiting

Intranasal Dexmedetomidine-esketamine Administration and Postoperative Pain in Pediatric Patients

Role: lead

NCT07246785Phase 4Terminated

Anrikefon-based Patient-controlled Intravenous Analgesia After Laparoscopic Surgery

Role: lead

NCT07517276Phase 2Not Yet Recruiting

TUDCA in High-Risk Lactating Mothers Identified by Early Postpartum Milk Hydrophobicity Index

Role: lead

NCT07256197Phase 3Not Yet Recruiting

PCSK9 Inhibitors in the Treatment of Calcific Aortic Stenosis

Role: collaborator

NCT07508852Phase 1Recruiting

68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer

Role: lead

NCT07504939Not Yet Recruiting

Multimodal Kidney-Sparing Strategy for High-Risk Upper Tract Urothelial Carcinoma

Role: lead

NCT07498907Phase 2Not Yet Recruiting

Disitamab Vedotin Plus Radiotherapy for Adjuvant Treatment of HER2-Expressing Cisplatin-Ineligible Upper Tract Urothelial Carcinoma

Role: lead

NCT05509296Not ApplicableCompleted

Compare the Effectiveness and Safety of Two Different Kinds of Cutting Balloon in Coronary Artery Disease

Role: collaborator

NCT07497841Not ApplicableCompleted

Development and Validation of a KAP Questionnaire for Secondary Hypertension: Evaluating a Community Short-Video Intervention in Rural Beijing

Role: lead